Mark N. Ho
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 1
- Bioactive natural compounds 1
- Histone Deacetylase Inhibitors Research 1
- Glycosylation and Glycoproteins Research 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Kevin D. Shenk (2 shared papers)Mark S. Smyth (2 shared papers)Maya Dajee (1 shared paper)Guy J. Laidig (2 shared papers)Evan R. Lewis (3 shared papers)Susan D. Demo (2 shared papers)Francesco Parlati (1 shared paper)Congcong Sun (2 shared papers)
- Partner nations
- United States
In The Last Decade
Mark N. Ho
5 papers receiving 593 citations
Mark N. Ho's Hit Papers
Peers
Comparison fields: 5 of 60
- Hematology 254
- Geriatrics and Gerontology 37
- Oncology 220
- Molecular Biology 494
- Genetics 48
Countries citing papers authored by Mark N. Ho
This map shows the geographic impact of Mark N. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Ho more than expected).
Fields of papers citing papers by Mark N. Ho
This network shows the impact of papers produced by Mark N. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Ho. The network helps show where Mark N. Ho may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark N. Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome Hit paper breakdown → | 2007 | 542 |
| 2 | 2006 | 61 | |
| 3 | 2005 | 2 | |
| 4 | In vitro metabolism and interaction studies with celecoxib and lovastatin. | 2004 | 2 |
| 5 | 2006 | 1 |
About Mark N. Ho
Mark N. Ho is a scholar working on Molecular Biology, Oncology, Pharmacology, Geriatrics and Gerontology and Hematology, having authored 5 papers that have together received 608 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Peptidase Inhibition and Analysis (2 papers), Inflammatory mediators and NSAID effects (1 paper), Protein Degradation and Inhibitors (1 paper), Bioactive natural compounds (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Estrogen and related hormone effects (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Hematology (254 citations), Geriatrics and Gerontology (37 citations), Oncology (220 citations), Molecular Biology (494 citations) and Genetics (48 citations). Mark N. Ho has collaborated with scholars based in United States. Frequent co-authors include Kevin D. Shenk, Mark S. Smyth, Maya Dajee, Guy J. Laidig, Evan R. Lewis, Susan D. Demo, Francesco Parlati, Congcong Sun, Marcy K. Vallone and Christopher J. Kirk. Their work appears in journals such as Blood, Journal of Pharmacy and Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.